2019
DOI: 10.1001/amajethics.2019.435
|View full text |Cite
|
Sign up to set email alerts
|

Palliative Care for Patients on Mechanical Circulatory Support

Abstract: Palliative care (PC) teams are primed to support patients with advanced illness, including patients with mechanical circulatory support (MCS), and are increasingly being called upon to help care for these patients. Detailed guidelines for PC engagement are lacking despite key stakeholders' endorsements of collaboration. PC needs to encompass the decision-making period, the duration of therapy, and end-of-life care. PC teams can assist with symptom management, advance care planning, and communication across the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…Initially developed as a bridge to transplantation, MCS currently is used for both short-and longterm support, ranging from hours to years, for a variety of indications and goals of care. 12,13 Overall 2-year survival is 70% among patients receiving MCS 12 ; however, morbidity in the form of debilitating stroke, significant bleeding, and infection continue to be significant barriers and challenges to patients, their families, and clinicians. As such, this relatively new form of life-sustaining therapy may cause high prognostic uncertainty and unacceptable quality of life.…”
mentioning
confidence: 99%
“…Initially developed as a bridge to transplantation, MCS currently is used for both short-and longterm support, ranging from hours to years, for a variety of indications and goals of care. 12,13 Overall 2-year survival is 70% among patients receiving MCS 12 ; however, morbidity in the form of debilitating stroke, significant bleeding, and infection continue to be significant barriers and challenges to patients, their families, and clinicians. As such, this relatively new form of life-sustaining therapy may cause high prognostic uncertainty and unacceptable quality of life.…”
mentioning
confidence: 99%
“…In traditional advanced heart failure centers, the care for these patients was provided by large multidisciplinary teams involving multiple coordinators, nurses, physician assistants, cardiothoracic surgeons, palliative care, and various advanced heart failure specialists. Due to the costs associated with such a large team, LVAD care was historically limited to large, urban medical facilities [15,16]. Post-transplantation inpatient cardiac rehabilitation allows patients to improve their functional status.…”
Section: Traditional Lvad Care Modelmentioning
confidence: 99%
“…The question may arise whether to deactivate these devices or to leave them active until the patient’s death [ 39 , 40 , 41 , 42 ].…”
Section: When Is the Right Moment To Discuss Cardiac Implantable Devi...mentioning
confidence: 99%